Jalaja Technologyis Pvt. Ltd has partnered the Council of Scientific and Industrial Research (CSIR) under the New Millennium Indian Technology Leadership Initiative (NMITILI) project for the development of customized Geno-Supercomputer based parallel processing for Bioinformatics.
The company will now take the opportunity to offer total solutions apart from assisting companies in the biotech space to set-up supercomputing environment infrastructure for Research and Bioinformatics labs across the country, stated Raja Seevan, director, Jalaja Technologyis Pvt. Ltd.
The company's maiden product PLHOSTFA (Peptide Library based Homology Search Tool Fast Alignment), a bio-informatics software which is patented in the USA, has already been sold to research and development institutes, academic as well as commercial entities in India. In addition, research firms in North America and South East Asia have also shown keen interest in the software.
The software is designed to assign functions to proteins which are the ubiquitous chemicals that govern virtually all processes in organisms like bacteria, plants, humans and viruses.
PLHOSTFA operates on People's Linux Desktop with Bio R&D tools that is integrated together on a workstation and provides a total solution. With the software, the scientists would only require to plug and play. Not only that People Linux is the first Indian system, which is user friendly and easy to migrate on other operating systems.
A key focus of the company is on marketing the indigenous software tools to educational institutions, research &development organization and the biotech-pharma industry.
"Our objective is to prove ourselves as a global leader by proliferating technology advancements," added Seevan. There have been a lot of enquiries from research centres including Bangalore's Indian Institute of Science, National Centre for Biological Sciences, Institute of Bioinformatics along with Hyderabad's GVK Biosciences, Indian Institute of Chemical Technology (IICT) and the Centre for Cell and Molecular Biology (CCMB). There are dialogues initiated with pharmaceutical companies including Nicholas Piramal, Procter & Gamble, Unilever, and Ocimum Biosolutions for its installation. The department of Biotechnology (DBT), government of India will also be using PLHOSTFA for all its institutions in the country as a total solutions provider, he informed.